EPLAW PATENT BLOG

Contact

Posted: September 29th, 2009

Should you have any comments, suggestions, cases, etc. please feel free to contact us at: editor@eplawpatentblog.com

READ MORE

Editorial Board

Posted: September 29th, 2009

The Editorial Board of the EPLAW Patent Blog consists of the following patent specialists: AustriaDominik Goebel -correspondent- (Gassauer-Fleissner Rechtsanwälte)   Belgium  Carina Gommers (HOYNG ROKH MONEGIER) Philippe de Jong (Altius) Philippe Campolini (Simont Braun)Christophe Ronse (Altius)   DenmarkAnders Valentin (Horten)   FinlandJohanna Lilja (Roschier) France Pauline Debre (Linklaters)Gwendal Barbaut (Independent Advisor) Stanislas Roux Vaillard (Hogan Lovells) Germany Kaya Köklü (Max-Planck-Institute for […]

READ MORE

Advisory Board

Posted: September 29th, 2009

The EPLAW Patent Blog Advisory Board helps define the editorial policy of the blog and ensures its quality. The Advisory Board consists of the following high-profile patent specialists:  – The Rt Hon. Professor Sir Robin Jacob, Sir Hugh Laddie Chair in intellectual property at University College London – Dr. Jochen Pagenberg (Bardehle Pagenberg) – Mr. […]

READ MORE

DK – Novartis v. Teva Denmark (Valsartan)

Posted: September 29th, 2009

Novartis AG and Novartis Healthcare A/S v. Teva Denmark A/S (Valsartan), Maritime and Commercial Court, Denmark, 29 September 2009, Docket No. T-32-08 Teva Denmark applied for a marketing authorization for a generic product which would (admittedly)  infringe upon the Novartis process patent if marketed. Novartis filed an application for an injunction prohibiting Teva from obtaining […]

READ MORE

Sponsors

Posted: September 28th, 2009

The EPLAW Patent Blog is grateful to its sponsors: AIPPI / VIE Arnold + Siedsma Bardehle Pagenberg BarentsKransBrinkhof Bristows  Dennemeyer EPLAW Fish & Richardson P.C. Hogan Lovells HOYNG ROKH MONEGIER Klos Morel Vos & Reeskamp Lindahl Plesner Powell Gilbert Roschier Sar and Partners Simont Braun Véron & Associés Vondst   The EPLAW Patent Blog is grateful […]

READ MORE

Advertisements

Posted: September 24th, 2009

The EPLAW Patent Blog offers a great platform to reach an international audience interested in patents and intellectual property and therefore is the perfect place for all your patent related advertisements. The advertising fees per banner add are: – One week: EUR 850– Two weeks: EUR 1600– Three weeks: EUR 2250– Four weeks: EUR 2800 – […]

READ MORE

About EPLAW Patent Blog

Posted: September 24th, 2009

The EPLAW Patent Blog aims to be a top-quality, free, independent European blog on patent law, providing speedy access to patent judgments and patent information from various European jurisdictions.    The blog intends to -over time- cover all relevant European national patent case law and news from all European jurisdictions. Also, the blog contains posts […]

READ MORE

DE – MP3 Player Import / infringement

Posted: September 17th, 2009

MP3 Player Import, infringement proceedings (liability of a shipping company), Federal Supreme Court, Germany, 17 September 2009, Docket No. Xa. ZR 2/08 A shipping company shipping patent infringing articles can be held responsible for patent infringement, if it does not clarify with reasonable effort whether the shipped articles are actually infringing or not immediately after […]

READ MORE

DE – Lundbeck v. Neolab Ltd. (Escitalopram) / invalidity

Posted: September 10th, 2009

Lundbeck A/S v. Neolab Ltd. et al. (Escitalopram), invalidity proceedings, Federal Supreme Court, Germany, 10 September 2009, Docket number Xa ZR 130/07 Patentability of an enantiomer over a known racemate. The Federal Supreme Court states that a publication from which it is apparent that there must be enantiomers of a chemical compound does not directly […]

READ MORE

DE – Füllstoff / infringement

Posted: September 10th, 2009

Füllstoff (Filler), infringement proceedings (prior use right), Federal Supreme Court, Germany, 10 September 2009, Docket No. Xa. ZR 18/08 An alleged patent infringer is not entitled to a prior use right by virtue of law, if there is a contractual agreement in place between the alleged patent infringer and the inventor and if the alleged […]

READ MORE